Praxis Precision Medicines, Inc. (PRAX) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18
	10-K	10-K	10-K	10-K	S-1/A
Revenues [+]	216.0	0.0	0.0	0.0	18.8
Royalties					18.8
Revenue growth				-100.0%
Cost of goods sold	0.0	0.0	0.0	0.0	22.7
Gross profit	216.0	0.0	0.0	0.0	-3.9
Gross margin	100.0%				-20.7%
Selling, general and administrative [+]	59.9	47.1	17.0	6.2	3.9
General and administrative	59.9	47.1	17.0	6.2	3.9
Research and development	155.0	120.3	45.0	29.6
Other operating expenses	215.0				14.9
EBITDA [+]	-213.6	-167.2	-61.9	-35.8	-22.7
EBITDA growth	27.8%	170.0%	73.2%	57.4%
EBITDA margin	-98.9%				-120.7%
Depreciation and amortization	0.4	0.2	0.1	0.0	0.0
EBIT [+]	-214.0	-167.3	-62.0	-35.8	-22.7
EBIT growth	27.9%	170.0%	73.1%	57.5%
EBIT margin	-99.1%				-120.7%
Non-recurring items	1.0
Interest income, net [+]	1.0	0.3	0.1	0.2	0.0
Interest expense					0.0
Interest income	1.0	0.3	0.1	0.2
Other income (expense), net	0.0				-3.6
Pre-tax income	-214.0	-167.1	-61.8	-35.6	-26.4
Income taxes	0.0	0.0	0.0	-0.1	0.1
Tax rate	0.0%	0.0%	0.0%	0.2%
Net income	-214.0	-167.1	-70.3	-40.7	-26.5
Net margin	-99.1%				-141.0%

Basic EPS [+]	($4.64)	($3.94)	($7.86)	($26.60)	($29,223.00)
Growth	18.0%	-49.9%	-70.5%	-99.9%
Diluted EPS [+]	($4.64)	($3.94)	($7.86)	($26.60)	($29,223.00)
Growth	18.0%	-49.9%	-70.5%	-99.9%

Shares outstanding (basic) [+]	46.1	42.5	9.0	1.5	0.0
Growth	8.6%	374.3%	485.1%	168358.1%
Shares outstanding (diluted) [+]	46.1	42.5	9.0	1.5	0.0
Growth	8.6%	374.3%	485.1%	168358.1%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.